Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2016-004188-38Phase 4Completed
Phase 4, open-label, single-arm trial of benzalkonium chloride in contraception, sponsored by InnoTech Precision Medicine. Primary endpoint: Contraceptive efficacy. Started Mar 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2016-004188-38.